LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about ALX Oncology…

ALX Oncology Tech Stack

ALX Oncology uses 8 technology products and services including Webpack, React, jQuery Migrate, and more. Explore ALX Oncology's tech stack below.

  • Webpack
    Development
  • React
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Smartsheet
    Project Management
  • Google
    Search Engines
  • reCAPTCHA
    Security
  • Cloudflare Bot Management
    Security
  • HSTS
    Security

Media & News

ALX Oncology's Email Address Formats

ALX Oncology uses at least 1 format(s):
ALX Oncology Email FormatsExamplePercentage
FLast@alxoncology.comJDoe@alxoncology.com
74%
First@alxoncology.comJohn@alxoncology.com
17%
Last@alxoncology.comDoe@alxoncology.com
6%
First.Last@alxoncology.comJohn.Doe@alxoncology.com
3%

Frequently Asked Questions

Where is ALX Oncology's headquarters located?

Minus sign iconPlus sign iconALX Oncology's main headquarters is located at 323 Allerton Ave, South San Francisco, California 94080, US. The company has employees across 4 continents, including North AmericaAfricaAsia.

What is ALX Oncology's stock symbol?

Minus sign iconPlus sign iconALX Oncology is a publicly traded company; the company's stock symbol is ALXO.

What is ALX Oncology's official website and social media links?

Minus sign iconPlus sign iconALX Oncology's official website is alxoncology.com and has social profiles on LinkedIn.

What is ALX Oncology's SIC code NAICS code?

Minus sign iconPlus sign iconALX Oncology's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ALX Oncology have currently?

Minus sign iconPlus sign iconAs of October 2025, ALX Oncology has approximately 67 employees across 4 continents, including North AmericaAfricaAsia. Key team members include Chief Executive Officer: J. L.Vice President Operations: M. C.Head Of Qa/Qc: C. L.. Explore ALX Oncology's employee directory with LeadIQ.

What industry does ALX Oncology belong to?

Minus sign iconPlus sign iconALX Oncology operates in the Biotechnology Research industry.

What technology does ALX Oncology use?

Minus sign iconPlus sign iconALX Oncology's tech stack includes WebpackReactjQuery MigrateSmartsheetGooglereCAPTCHACloudflare Bot ManagementHSTS.

What is ALX Oncology's email format?

Minus sign iconPlus sign iconALX Oncology's email format typically follows the pattern of FLast@alxoncology.com. Find more ALX Oncology email formats with LeadIQ.

How much funding has ALX Oncology raised to date?

Minus sign iconPlus sign icon As of October 2025, ALX Oncology has raised $105M in funding. The last funding round occurred on Feb 12, 2020 for $105M.

When was ALX Oncology founded?

Minus sign iconPlus sign iconALX Oncology was founded in 2015.

ALX Oncology

Biotechnology ResearchUnited States51-200 Employees

ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives. ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications.

Section iconCompany Overview

Headquarters
323 Allerton Ave, South San Francisco, California 94080, US
Website
alxoncology.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ALXO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $105M

    ALX Oncology has raised a total of $105M of funding over 1 rounds. Their latest funding round was raised on Feb 12, 2020 in the amount of $105Mas a Series C.

  • $25M$50M

    ALX Oncology's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $105M

    ALX Oncology has raised a total of $105M of funding over 1 rounds. Their latest funding round was raised on Feb 12, 2020 in the amount of $105Mas a Series C.

  • $25M$50M

    ALX Oncology's revenue is estimated to be in the range of $25M$50M

Company Leadership

  • Stylized image of a person
    J. L.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. C.
    Vice President Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. L.
    Head Of Qa/Qc
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. T.
    Senior Vice President, Clinical Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. S.
    Vice President, Medical Affairs
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    C. L.
    Head Of Qa/Qc
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. Q.
    Vice President, Clincal Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. M.
    Director Of Translational Oncology - Clinical Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. O.
    Executive Director, Global Regulatory Affairs Cmc
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. M.
    Director, Biostatistics
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.